Donna Rill
Chief Technology Officer, Triumvira Immunologics USA, Inc
Ms. Rill is currently serving as the Chief Technical Officer of Triumvira Immunologics, USA,
Inc. She has extensive manufacturing, clinical and translational research laboratory experience
in cell and gene therapy, monoclonal antibody production, and protein production.
She has setup and managed core development laboratories covering a large range of testing
services to facilitate research, core drug development activities as well as manufacturing
and quality control laboratories. With her expertise in the areas of laboratory construction,
project management, development and operations, cGMP, cGTP, and GLP regulatory compliance,
quality control/assurance system, database development, and clinical standards of
practice, she has designed and qualified cGMP Cell & Gene Therapy Laboratories, cGMP
Vector Production facilities, core service laboratories, and Translational Research Labs. Ms.
Rill has previously held the positions of Vice President of Manufacturing for Cell Medica,
Chief Development Officer for Opexa Therapeutics, Laboratory Director of Cell and Gene
Therapy, Translational Research Laboratories for Cell and Gene Therapy, Baylor College
of Medicine; Associate Scientist/Lab Manager of the Bone Marrow Transplant Research
Laboratory, and the GMP Cell and Gene Therapy Laboratories, St. Jude Children’s Research
Hospital; Education Coordinator and Clinical Instructor, Department of Clinical Laboratory,
LeBonheur Children’s Medical Center and University of Tennessee Center for the Health
Sciences.
